Introduction to the hotspots and forefront of 2018 Myasthenia Gravis Foundation of America′s Scientific Session
10.3760/cma.j.issn.1006-7876.2019.09.017
- VernacularTitle: 2018年美国重症肌无力基金会科学会议热点与前沿
- Author:
Hao RAN
1
;
Weibin LIU
2
Author Information
1. School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China
2. Department of Neurology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
- Publication Type:Journal Article
- Keywords:
Myasthenia gravis;
Congresses
- From:
Chinese Journal of Neurology
2019;52(9):790-792
- CountryChina
- Language:Chinese
-
Abstract:
The authors introduced the hotspots and forefront of 2018 Myasthenia Gravis Foundation of America′s Scientific Session, including the research forefront and trend of the following: International research hotspots in the myasthenia gravis (MG) had been changed from the most common acetylcholine receptor antibody positive MG (AChR-MG) into other subtypes, particularly muscle specific tyrosine kinase receptor antibody positive MG; The efficacy of thymectomy was effective in the whole AChR-MG group, but not in other MG subgroups; Existing drugs in MG treatment can not achieve the expected effect, so endless new drug development had become a hot field of MG research; In terms of basic research, more attention had been paid to exploring the specific mechanisms involved in MG pathogenesis, including the study of antigen specific B cells and even antigen specific T cells.
